This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Brown Rudnick Selected To Represent The Official Committee Of Unsecured Creditors In New England Compounding Center Case

BOSTON, Jan. 22, 2013 /PRNewswire/ -- New England Compounding Center (NECC), the Massachusetts compounding pharmacy at the center of the nation's deadly fungal meningitis outbreak, revealed in bankruptcy court filings late on Friday, January 18 that since December 2011 it had paid more than $21 million to NECC's four primary owners, Barry Cadden, Gregory Conigliaro, Carla Conigliaro and Lisa Conigliaro-Cadden, and other NECC insiders.

Details of these insider transfers can be found in the court filings. See US Bankruptcy Court Case 12-19882, Doc 68, Filed 01/18/13, Document Pages 166 of 208.

Brown Rudnick LLP on Friday was selected to represent the Official Committee of Unsecured Creditors in the bankruptcy of NECC, including the victims who received injections of tainted steroids traced to NECC.  The Committee and Brown Rudnick are examining information concerning money transfers to insiders and considering the appropriate legal responses.

A hearing is scheduled for Thursday, January 24 at the U.S. Bankruptcy Court in Springfield, Massachusetts as to whether the Court should order an independent trustee to replace NECC's board of directors.

"NECC has shown a shocking disregard for safety measures that should have been followed in its facility after failing inspection after inspection for years," said William R. Baldiga, a partner at Brown Rudnick representing the Creditor Committee. "The company was operating under unsafe conditions, yet clearly had the funds to ensure its compliance with all appropriate regulations to protect the health and well being of patients to be injected with its products."

"The Committee's statutory duty is to help ensure that the property of the estate is protected, taken under control of the estate and made available to victims and creditors with claims against the company," commented Brown Rudnick partner David Molton, who also represents the Committee.  Molton continued, "It is disturbing that significant amounts of company property were taken by insiders during the same period when they were permitting abhorrent conditions at the company that ultimately led to the injury and death of innocents."

"We may still be at the tip of the iceberg in terms of the number of victims who will become ill or die as result of receiving injections of the tainted material," say Anne Andrews of Andrews & Thornton, Irvine, Calif. and Harry Roth of Cohen Placitella & Roth PC, Philadelphia, PA, Co-Chairs of the Official Committee of Unsecured Creditors. "New victims are emerging who instead of coming down with meningitis, have developed fungal abscesses that are almost impossible to treat. Tragically, many individuals have yet to realize they have been sickened with an abscess, and have yet to be diagnosed. The bankruptcy process will help to identify these now silent victims so they too can be treated fairly in this process. The vast medical complications of this tragedy have yet to be fully understood as the number of victims mount." 

To date, the outbreak has already killed 44 people and sickened 678, according to the U.S. Centers for Disease Control and Prevention.  More than 14,000 people have been exposed to the drugs, which are injected to ease back pain.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs